Issue · May 2026New this week: evidence-first longevity readsThe newsletter — one essay, Sunday morningsArchive access — every article, free to readPodcast coming soon — NotebookLM sessionsLetters from readers — reply to any emailIssue · May 2026New this week: evidence-first longevity readsThe newsletter — one essay, Sunday morningsArchive access — every article, free to readPodcast coming soon — NotebookLM sessionsLetters from readers — reply to any email
Edited for you

Recommendations for the week ahead

Browse the full archive →
FilterSort
The GLP-1 Side Effect List Your Doctor Probably Won't Mention
Weight Loss

The GLP-1 Side Effect List Your Doctor Probably Won't Mention

Most patients on Ozempic, Wegovy, or Zepbound hear about nausea and stop there. The full safety profile includes lean muscle loss, sulfur burps, gallstones, NAION vision risk, anesthesia warnings, and more. A research-grounded guide to what gets left out of the 15-minute appointment.

Apr 27 · 16 min readBy J. (JessieLew)
The long read

A slower piece, on one thing.

All long reads →
I Tried Semaglutide for 90 Days: The Honest Before-and-After Nobody Talks About
Weight Loss · In-depth essay

I Tried Semaglutide for 90 Days: The Honest Before-and-After Nobody Talks About

What 90 days of semaglutide actually changes — pulled from STEP-1, STEP-4, and real-world cohorts, not marketing photos.

Begin reading13 min readBy Jessica Lewis (JessieLew)
Letter from the editorial team

On the quiet parts of getting well.

Oral BPC-157 is convenient and injectable BPC-157 is more targeted, but neither route is proven for joint repair in high-quality human trials.

The goal isn’t to be comfortable with change — it’s to be comfortable with one small change, on a schedule, held for a year.

From “BPC-157 Oral vs. Injection: Which Form Actually Works for Joint Repair?” · The HL Benefits Editorial Team · May 2026
By topic

What we’re reading across the desks.

See all categories →
The Quiet Podcast · Coming soon

Notebook-LM reads the magazine — deep-dive conversations, weekly.

We’re recording with NotebookLM. Expect a deep-dive and a short-form version of each issue’s best essays, delivered to your favorite podcast app when we launch.

42 min · launching soonSubscribe to get the first episode
The daily read · Free

One essay, every morning. No theatre.

A short email with the day’s best piece, a quote we’re sitting with, and links we actually read. No upsell, no course. Unsubscribe in one click.

456Essays

By subscribing, you agree to our privacy policy.